Refractory cancers
Showing 1 - 25 of >10,000
Refractory Cancer, Relapsed Cancer Trial in Weston (Drug Sensitivity Test (DST))
Not yet recruiting
- Refractory Cancer
- Relapsed Cancer
- Drug Sensitivity Test (DST)
-
Weston, FloridaLerner College of Medicine: Cleveland Clinic Florida
Sep 1, 2023
Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial in Houston (Laboratory
Completed
- Advanced Malignant Solid Neoplasm
- +3 more
- Laboratory Biomarker Analysis
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 21, 2022
Advanced, Pretreated Solid Tumors Trial in Villejuif (Biopsy)
Recruiting
- Advanced, Pretreated Solid Tumors
- Biopsy
-
Villejuif, FranceGustave Roussy
Feb 23, 2022
Lung Cancer, Bilateral Cancer, Lung Transplant Trial in Chicago (Double Lung Transplantation)
Recruiting
- Lung Cancer
- +2 more
- Double Lung Transplantation
-
Chicago, IllinoisThoracic Surgery, Canning Thoracic Institute (Northwestern Memor
Jan 23, 2023
Non Hodgkin Lymphoma Trial (TMhuCART19-IL18)
Not yet recruiting
- Non Hodgkin Lymphoma
- TMhuCART19-IL18
- (no location specified)
Aug 2, 2023
Hepatocellular Carcinoma, Hepatocellular Cancer, Metastatic Pancreatic Cancer Trial run by the NCI (nivolumab, tadalafil, oral
Completed
- Hepatocellular Carcinoma
- +4 more
- nivolumab
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Constitutional Mismatch Repair Deficiency Syndrome, Hematopoietic and Lymphoid Cell Tumor, Lynch Syndrome Trial in Canada,
Withdrawn
- Constitutional Mismatch Repair Deficiency Syndrome
- +11 more
- Biospecimen Collection
- +2 more
-
Palo Alto, California
- +8 more
Sep 9, 2022
Colon Cancer, Colorectal Cancer, Colorectal Carcinoma Trial in Tampa (Pembrolizumab, Ibrutinib)
Completed
- Colon Cancer
- +3 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jun 1, 2022
Metastatic Thyroid Cancer Trial in Essen (Trametinib 2 MG [Mekinist], Trametinib 2 MG [Mekinist] and Dabrafenib 75 MG (2-0-2)
Recruiting
- Metastatic Thyroid Cancer
- Trametinib 2 MG [Mekinist]
- Trametinib 2 MG [Mekinist] and Dabrafenib 75 MG (2-0-2) [Tafinlar]
-
Essen, Northrhine-Westphalia, GermanyManuel M. Weber
May 17, 2022
Neuroendocrine Tumor (NET), Colorectal Cancer (CRC) Trial (CHM-2101 CAR-T cells)
Not yet recruiting
- Neuroendocrine Tumor (NET)
- Colorectal Cancer (CRC)
- CHM-2101 CAR-T cells
- (no location specified)
Sep 20, 2023
Thyroid Cancer Trial in Ghent (PET/CT scan F18-PSMA-11)
Recruiting
- Thyroid Cancer
- PET/CT scan F18-PSMA-11
-
Ghent, BelgiumUniversity hospital Ghent
Feb 7, 2022
Cancer, Pediatric Solid Tumor, Pediatric AML Trial in Australia, United Kingdom (PEG- BCT-100)
Completed
- Cancer
- +3 more
- PEG- BCT-100
-
Adelaide, Australia
- +13 more
Sep 1, 2022
Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Trametinib
Active, not recruiting
- Advanced Lymphoma
- +5 more
- Trametinib Dimethyl Sulfoxide
-
Philadelphia, PennsylvaniaECOG-ACRIN Cancer Research Group
Aug 13, 2022
Oropharyngeal Cancer, Human Papilloma Virus, Head Neck Cancer Trial (Fludarabine, Cyclophosphamide, NEXI-003 T cells)
Not yet recruiting
- Oropharyngeal Cancer
- +10 more
- Fludarabine
- +2 more
- (no location specified)
Dec 14, 2022
Small Cell Lung Carcinoma, Neuroendocrine Tumors Trial (BI 764532)
Not yet recruiting
- Small Cell Lung Carcinoma
- Neuroendocrine Neoplasms
- BI 764532
- (no location specified)
May 22, 2023
Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Capivasertib)
Active, not recruiting
- Advanced Lymphoma
- +5 more
-
Philadelphia, PennsylvaniaECOG-ACRIN Cancer Research Group
Jun 28, 2022
Advanced Cancers, Pain Trial in Houston (Cordotomy, Pain/Symptom Questionnaire, Sharpness Sensory Testing)
Completed
- Advanced Cancers
- Pain
- Cordotomy
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jun 29, 2022
Neuroblastoma, Osteosarcoma, Other Solid Tumor Cancers Trial in New York (Humanized 3F8 Bispecific Antibody, Blood draw)
Terminated
- Neuroblastoma
- +2 more
- Humanized 3F8 Bispecific Antibody
- Blood draw
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jul 11, 2022
Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Defactinib
Active, not recruiting
- Advanced Lymphoma
- +5 more
- Defactinib Hydrochloride
-
Philadelphia, PennsylvaniaECOG-ACRIN Cancer Research Group
Jun 28, 2022
Opioid-Related Disorders, Pain Management, Pain Management and Care Trial in Boston (Psilocybin)
Not yet recruiting
- Opioid-Related Disorders
- +4 more
-
Boston, Massachusetts
- +2 more
Aug 14, 2023
Acute Myeloid Leukemia, Relapsed Cancer, Refractory Cancer Trial in Edmonton, Toronto (Enasidenib, Venetoclax)
Active, not recruiting
- Acute Myeloid Leukemia
- +3 more
-
Edmonton, Alberta, Canada
- +1 more
Jan 31, 2023